Practice changing data and emerging concepts from recent radiation therapy randomised clinical trials

被引：6

作者：

Espenel, Sophie ^{[1
,6
]}

Chargari, Cyrus ^{[1
,2
]}

Blanchard, Pierre ^{[1
,3
,4
]}

Bockel, Sophie ^{[1
]}

Morel, Daphne ^{[1
]}

Rivera, Sofia ^{[1
,5
]}

Levy, Antonin ^{[1
,3
,5
]}

Deutsch, Eric ^{[1
,3
,5
,7
]}

机构：

[1] Gustave Roussy, Dept Radiotherapie, F-94805 Villejuif, France

[2] Inst Rech Biomed Armees, F-91220 Bretigny Sur Orge, France

[3] Univ Paris Saclay, Fac Med, F-94270 Le Kremlin Bicetre, France

[4] Inserm U 1018, Oncostat, F-94805 Villejuif, France

[5] Univ Paris Saclay, Inserm U 1030, Lab Radiotherapie Mol & Innovat Thrapeut, 1030, F-94805 Villejuif, France

[6] Gustave Roussy Canc Campus, Dept Radiat Oncol, 114 Rue Edouard Vaillant, F-94800 Villejuif, France

[7] Radiat Oncol Dept, Villejuif, France

来源：

EUROPEAN JOURNAL OF CANCER | 2022年 / 171卷

关键词：

Radiotherapy; Practice changing data; Randomised; Hypofractionated; Quality of life; Shared decision making; PHASE-III TRIAL; INTENSITY-MODULATED RADIOTHERAPY; BREAST-CONSERVING SURGERY; SQUAMOUS-CELL CARCINOMA; STEREOTACTIC BODY RADIOTHERAPY; RISK PROSTATE-CANCER; QUALITY-OF-LIFE; OPEN-LABEL; NEOADJUVANT CHEMORADIOTHERAPY; NON-INFERIORITY;

D O I：

10.1016/j.ejca.2022.04.038

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: Oncology treatments are constantly and rapidly evolving. We aimed at highlighting the latest radiation therapy practice changing trials and emerging concepts, through an overview of recent randomised clinical trials (RCTs). Materials and methods: Requests were performed in the Medline database to identify all publications reporting radiation therapy RCTs from 2018 to 2021. Results: Recent RCTs sustained the role of newer combinatorial strategies through radioimmunotherapy for early stage or metastatic lung cancer, newer pro-apoptotic agents (e.g. debio 1143 in locoregionally advanced head and neck squamous cell carcinoma) or nanoparticles (e.g. NBTXR3 in locally advanced soft-tissue sarcoma). High-tech radiotherapy allows intensifying treatments and gaining ground in some indications through the development of stereo tactic body radiotherapy for example. First randomised evidence on personalised radiation therapy through imaging-based ((18)FDG positron emission tomography-computed tomography for lung cancer or early stage unfavourable Hodgkin lymphoma, PMSA positron emission tomography-computed tomography or magnetic resonance imaging for high-risk prostate cancer) or biological biomarkers (PSA for prostate cancer, HPV for head and neck cancer, etc) were conducted to more tailored treatments, with more favourable outcomes. Patients' quality of life and satisfaction appeared to be increasing aims. RCTs have validated (ultra)hypofractionated schemes in many indications as for breast, prostate or rectal cancer, resulting in equivalent outcomes and toxicities, more convenient for patients and favouring shared decision making. Conclusion: Radiation therapy is a dynamic field of research, and many RCTs have greatly impacted therapeutic standards over the last years. Investments in radiotherapy research should facilitate the transfer of innovation to clinic. (C) 2022 Elsevier Ltd. All rights reserved.

引用

页码：242 / 258

页数：17

共 105 条

[1] Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial [J].

Altorki, Nasser K. ;

McGraw, Timothy E. ;

Borczuk, Alain C. ;

Saxena, Ashish ;

Port, Jeffrey L. ;

Stiles, Brendon M. ;

Lee, Benjamin E. ;

Sanfilippo, Nicholas J. ;

Scheff, Ronald J. ;

Pua, Bradley B. ;

Gruden, James F. ;

Christos, Paul J. ;

Spinelli, Cathy ;

Gakuria, Joyce ;

Uppal, Manik ;

Binder, Bhavneet ;

Elemento, Olivier ;

Ballman, Karla, V ;

Formenti, Silvia C. .

LANCET ONCOLOGY, 2021, 22 (06) :824-835

[2] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].

Antonia, S. J. ;

Villegas, A. ;

Daniel, D. ;

Vicente, D. ;

Murakami, S. ;

Hui, R. ;

Kurata, T. ;

Chiappori, A. ;

Lee, K. H. ;

de Wit, M. ;

Cho, B. C. ;

Bourhaba, M. ;

Quantin, X. ;

Tokito, T. ;

Mekhail, T. ;

Planchard, D. ;

Kim, Y. -C. ;

Karapetis, C. S. ;

Hiret, S. ;

Ostoros, G. ;

Kubota, K. ;

Gray, J. E. ;

Paz-Ares, L. ;

Carpeno, J. de Castro ;

Faivre-Finn, C. ;

Reck, M. ;

Vansteenkiste, J. ;

Spigel, D. R. ;

Wadsworth, C. ;

Melillo, G. ;

Taboada, M. ;

Dennis, P. A. ;

Ozguroglu, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350

[3]

Attard G, 2021, LANCET

[4] Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer [J].

Avkshtol, Vladimir ;

Ruth, Karen J. ;

Ross, Eric A. ;

Hallman, Mark A. ;

Greenberg, Richard E. ;

Price, Robert A., Jr. ;

Leachman, Brooke ;

Uzzo, Robert G. ;

Ma, Charlie ;

Chen, David ;

Geynisman, Daniel M. ;

Sobczak, Mark L. ;

Zhang, Eddie ;

Wong, Jessica K. ;

Pollack, Alan ;

Horwitz, Eric M. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) :1676-+

[5] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial [J].

Bahadoer, Renu R. ;

Dijkstra, Esmee A. ;

van Etten, Boudewijn ;

Marijnen, Corrie A. M. ;

Putter, Hein ;

Kranenbarg, Elma Meershoek-Klein ;

Roodvoets, Annet G. H. ;

Nagtegaal, Iris D. ;

Beets-Tan, Regina G. H. ;

Blomqvist, Lennart K. ;

Fokstuen, Tone ;

ten Tije, Albert J. ;

Capdevila, Jaume ;

Hendriks, Mathijs P. ;

Edhemovic, Ibrahim ;

Cervantes, Andres ;

Nilsson, Per J. ;

Glimelius, Bengt ;

van de Velde, Cornelis J. H. ;

Hospers, Geke A. P. .

LANCET ONCOLOGY, 2021, 22 (01) :29-42

[6] Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675) [J].

Belderbos, Jose S. A. ;

De Ruysscher, Dirk K. M. ;

De Jaeger, Katrien ;

Koppe, Friederike ;

Lambrecht, Maarten L. F. ;

Lievens, Yolande N. ;

Dieleman, Edith M. T. ;

Jaspers, Jaap P. M. ;

Van Meerbeeck, Jan P. ;

Ubbels, Fred ;

Kwint, Margriet H. ;

Kuenen, Marianne A. ;

Deprez, Sabine ;

De Ruiter, Michiel B. ;

Boogerd, Willem ;

Sikorska, Karolina ;

Van Tinteren, Harm ;

Schagen, Sanne B. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (05) :840-849

[7] NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2-3, randomised, controlled trial [J].

Bonvalot, Sylvie ;

Rutkowski, Piotr L. ;

Thariat, Juliette ;

Carrere, Sebastien ;

Ducassou, Anne ;

Sunyach, Marie-Pierre ;

Agoston, Peter ;

Hong, Angela ;

Mervoyer, Augustin ;

Rastrelli, Marco ;

Moreno, Victor ;

Li, Rub K. ;

Tiangco, Beatrice ;

Herraez, Antonio Casado ;

Gronchi, Alessandro ;

Mangel, Laszlo ;

Sy-Ortin, Teresa ;

Hohenberger, Peter ;

de Baere, Thierry ;

Le Cesne, Axel ;

Helfre, Sylvie ;

Saada-Bouzid, Esma ;

Borkowska, Aneta ;

Anghel, Rodica ;

Co, Ann ;

Gebhart, Michael ;

Kantor, Guy ;

Montero, Angel ;

Loong, Herbert H. ;

Verges, Ramona ;

Lapeire, Lore ;

Dema, Sorin ;

Kacso, Gabriel ;

Austen, Lyn ;

Moureau-Zabotto, Laurence ;

Servois, Vincent ;

Wardelmann, Eva ;

Terrier, Philippe ;

Lazar, Alexander J. ;

Bovee, Judith V. M. G. ;

Le Pechoux, Cecile ;

Papi, Zsusanna .

LANCET ONCOLOGY, 2019, 20 (08) :1148-1159

[8] Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial [J].

Bonvolot, Sylvie ;

Gronchi, Alessandro ;

Le Pechoux, Cecile ;

Swallow, Carol J. ;

Strauss, Dirk ;

Meeus, Pierre ;

van Coevorden, Frits ;

Stoldt, Stephan ;

Stoeckle, Eberhard ;

Rutkowski, Piotr ;

Rastrelli, Marco ;

Rout, Chandrajit P. ;

Hompes, Daphne ;

De Paoli, Antonino ;

Sangalli, Claudia ;

Honore, Charles ;

Chung, Peter ;

Miah, Aisha ;

Blay, Jean Yves ;

Fiore, Marco ;

Stelmes, Jean-Jacques ;

Dei Tos, Angelo P. ;

Baldini, Elizabeth H. ;

Litiere, Saskia ;

Marreaud, Sandrine ;

Gelderblom, Hans ;

Haas, Rick L. .

LANCET ONCOLOGY, 2020, 21 (10) :1366-1377

[9]

Borchmann P, 2021, LANCET ONCOL, V22, P223, DOI 10.1016/S1470-2045(20)30601-X

[10] Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer [J].

Bradley, Jeffrey D. ;

Hu, Chen ;

Komaki, Ritsuko R. ;

Masters, Gregory A. ;

Blumenschein, George R. ;

Schild, Steven E. ;

Bogart, Jeffrey A. ;

Forster, Kenneth M. ;

Magliocco, Anthony M. ;

Kavadi, Vivek S. ;

Narayan, Samir ;

Iyengar, Puneeth ;

Robinson, Clifford G. ;

Wynn, Raymond B. ;

Koprowski, Christopher D. ;

Olson, Michael R. ;

Meng, Joanne ;

Paulus, Rebecca ;

Curran, Walter J., Jr. ;

Choy, Hak .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) :706-+

← 1 2 3 4 5 6 7 8 9 10 →